Insulet | PODD - Trade Debtors


Insulet reported $516.9M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
Align Technology USD 1.1B 2.38M Dec/2025
AtriCure USD 66.65M 3.67M Dec/2025
Avanos Medical USD 103.8M 7.7M Dec/2025
Baxter International USD 2.01B 231M Dec/2025
Becton, Dickinson and Co. USD 2.51B 486M Dec/2025
Boston Scientific USD 2.83B 13M Sep/2025
Cardinal Health USD 13.66B 108M Dec/2025
Cooper Companies USD 829M 36.7M Sep/2025
Dexcom USD 1.28B 167.3M Dec/2025
Edwards Lifesciences USD 892.8M 9.8M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Globus Medical USD 743.66M 55.54M Dec/2025
ICU Medical USD 180.52M 11.03M Dec/2025
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 516.9M 54.7M Dec/2025
Integra LifeSciences USD 278.85M 16.69M Dec/2025
J&J USD 17.61B 235M Sep/2025
Masimo USD 355.9M 69.4M Sep/2025
Medtronic USD 6.39B 126M Sep/2025
Merit Medical Systems USD 223.61M 7.9M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Solventum Corp USD 1.18B 79M Sep/2025
Stryker USD 4.04B 396M Dec/2025
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 345.58M 247.07M Dec/2025
West Pharmaceutical Services USD 574.4M 50.6M Dec/2025
Zimmer Biomet Holdings USD 1.7B 106.1M Dec/2025